InvestorsHub Logo
Followers 40
Posts 4472
Boards Moderated 0
Alias Born 02/28/2018

Re: None

Saturday, 03/12/2022 8:37:24 PM

Saturday, March 12, 2022 8:37:24 PM

Post# of 113774
Sunshines Ace in the Hole

Recent biochemical studies have revealed many underlying similarities among these diseases at the sub-cellular level. These similarities suggest that a given therapeutic approach for one neurodegenerative disease might ameliorate other diseases in the class.



We are heartened by this recent finding in our ongoing mRNA-as-therapeutic-agents research that certain mRNA molecules provide differentiated neuronal cells full protection against hydrogen peroxide induced oxidative stress, a system commonly used to study neurodegeneration in vitro,” said Dr. Steve Slilaty, CEO of Sunshine Biopharma. “We are excited about this discovery for patients suffering from neurodegenerative disorders. Our possible mRNA treatment could arrest progression of neurodegeneration, alleviate symptoms, relieve pain, and increase mobility,” he added.



https://www.globenewswire.com/news-release/2021/10/06/2309510/35334/en/Sunshine-Biopharma-Files-a-Patent-Application-Covering-mRNA-Molecules-for-Treatment-of-Neurodegenerative-Diseases.html

Buy More $SBFM Its a Cancer and COVID Killer

But do Your Own DD

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News